Dr. Mark Socinski, international leader in the field of lung cancer, from the University of North Carolina at Chapel Hill, gave a terrific presentation on timing and selection of treatment after the first line setting for advanced NSCLC. In addition to the podcast of his presentation itself, here now is the question and answer session that followed it.
The Q&A portion includes slides with the questions as well as some slides that illustrate key points. Below, you'll find the audio and video versions of the podcast, the figures, and also the transcript of the program.
We are very grateful to Eli Lilly Oncology for the educational grant that supported this activity. Eli Lilly had no input in the development of any of its content.